跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CAPECITABINE-DRLA capecitabine 500 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
CAPECITABINE-DRLA capecitabine 500 mg tablet blister pack
Approved
STANDARD
CAPECITABINE-DRLA capecitabine 500 mg tablet blister pack
Dr Reddys Laboratories Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b898a651d8c3e1a5
Company
Dr Reddys Laboratories Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
b898a651d8c3e1a5
Product Name
CAPECITABINE-DRLA capecitabine 500 mg tablet blister pack
Artg Id
200933
Artg Name
CAPECITABINE-DRLA capecitabine 500 mg tablet blister pack
Sponsor
Dr Reddys Laboratories Australia Pty Ltd
Company Detail Path
/organization/dr-reddys-laboratories-australia-pty-ltd
Artg Date
2013-06-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8b9aa615a57a496900f3c3a1bc3de427.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/b1adb409b4ab4d289996a73afe81ac88.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b898a651d8c3e1a5
Type
Standard
Back to TGA Approvals